Publicaciones en las que colabora con Pablo Sarobe Ugarriza (14)

2024

  1. Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort

    Science Advances, Vol. 10, Núm. 28

  2. Non-canonical ORFs are an important source of tumor-specific antigens in a liver cancer meta-cohort

    figshare

  3. Non-canonical ORFs are an important source of tumor-specific antigens in a liver cancer meta-cohort

    figshare

  4. Non-canonical ORFs are an important source of tumor-specific antigens in a liver cancer meta-cohort

    figshare

  5. Non-canonical ORFs are an important source of tumor-specific antigens in a liver cancer meta-cohort

    figshare

  6. Relevance of mutation-derived neoantigens and non-classical antigens for anticancer therapies

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

2023

  1. Non-canonical ORFs are an important source of neoantigens in patient tumors

    figshare

  2. Non-canonical ORFs are an important source of tumor-specific antigens in a liver cancer meta-cohort

    figshare

2022

  1. Gemcitabine-mediated depletion of immunosuppressive dendritic cells enhances the efficacy of therapeutic vaccination

    Frontiers in Immunology, Vol. 13

  2. Identification of HLA class I-restricted immunogenic neoantigens in triple negative breast cancer

    Frontiers in Immunology, Vol. 13

2015

  1. Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection

    Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006

  2. Immune monitoring of immunosuppression withdrawal of liver transplant recipients

    Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116

  3. Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

    Liver International, Vol. 35, Núm. 5, pp. 1590-1596

2013

  1. Trial of complete weaning from immunosuppression for liver transplant recipients: Factors predictive of tolerance

    Liver Transplantation, Vol. 19, Núm. 9, pp. 937-944